منابع مشابه
Pharmacy benefit spending on oral chemotherapy drugs.
BACKGROUND Pharmacy benefits have historically excluded injectable drugs, resulting in coverage of injectable drugs under the medical benefit. High-cost biologics and other new drug therapies are often injectables and therefore have not presented cost threats to pharmacy benefits. The U.S. Food and Drug Administration approval of capecitabine, an oral form of fluorouracil, in 1998, and imatinib...
متن کاملPharmacy benefit managers: a model for Medicare?
This issue brief uses large employer experiences with pharmacy benefit managers (PBMs) to shed light on their potential as Medicare outpatient drug benefit administrators. PBM management techniques and typical employer approaches are discussed, as well as employer perspectives on PBM strengths and weaknesses and lessons learned. Considerations for Medicare policy are also examined. Information ...
متن کاملSome Medical Benefit Changes
a resident caretaker and telephonic communication, proper notices to the patients and adequate deputising arrangements. Without these, the lock-up surgery will always be a reproach to the panel service. In future the Panel Committee may require the Insurance Committee to have an investigation made, either into the conduct of an individual doctor or into any matter affecting the administration o...
متن کاملPharmacy benefit managers, pharmacies, and pharmacogenomic testing: prescription for progress?
Few would argue that the ability to match individual patients with the safest and most effective drugs and doses would be a major advance for clinical medicine. But while clinicians have been reluctant to routinely use pharmacogenomic analyses to guide their prescribing practices, pharmacy benefit managers and drugstores are proceeding with major pharmacogenetic initiatives.
متن کاملA blueprint for pharmacy benefit managers to increase value.
Pharmacy benefit managers (PBMs) have a unique opportunity to promote health and generate value in the healthcare system. Today, PBMs are largely evaluated on their ability to control costs rather than improve health. Pharmacy benefit managers should be evaluated along 3 dimensions in which they can increase value: (1) use of cost-effective medications, (2) timely initiation of appropriate medi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pharmacy Today
سال: 2015
ISSN: 1042-0991
DOI: 10.1016/s1042-0991(15)30134-1